teriflunomide
Aubagio · ATC code L04AK02
Also known as: Teriflunomid · Brand names: Aubagio, Terebyo, Teriflunomid +pharma, Teriflunomid Devatis, Teriflunomid Genericon, Teriflunomid Glenmark, Teriflunomid Hcs, Teriflunomid Ratiopharm, Teriflunomid Stada, Teriflunomid Zentiva, Teriflunomide G.L., Teriflago, Teriflu Viatris, Theditrax, Avonomide …
- Key facts
- Active substance
- teriflunomide
- Drug class
- Immunosuppressive drug
- ATC code
- L04AK02
- Authorisation
- centrally authorised across the EU (EMA)
- Dosage forms
- AUBAGIO 7 mg film-coated tablets / AUBAGIO 14 mg film-coated tablets
- Marketing authorisation holder
- Sanofi Winthrop Industrie
- Information as of
- 2026-10-28
Key facts
Teriflunomide (Aubagio) is an oral immunomodulator, the main metabolite of leflunomide, used to treat relapsing remitting multiple sclerosis.
What it is used for
- Relapsing remitting multiple sclerosis (MS) in adults and paediatric patients aged 10 years and older.
Dosing
- Adults: 14 mg once daily, with or without food, swallowed whole.
- Children from 10 years: >40 kg 14 mg once daily; ≤40 kg 7 mg once daily; switch to 14 mg once a stable weight above 40 kg is reached.
- No dose adjustment in mild to severe renal impairment without dialysis or in mild and moderate hepatic impairment; use with caution from 65 years.
Contraindications
- Hypersensitivity to the active substance or any excipient; severe hepatic impairment (Child-Pugh C).
- Pregnancy, and women of childbearing potential not using reliable contraception while plasma levels are above 0.02 mg/l; breast-feeding.
- Severe immunodeficiency (e.g. AIDS), significantly impaired bone marrow function or significant cytopenias; severe active infection until resolved.
- Severe renal impairment on dialysis; severe hypoproteinaemia (e.g. nephrotic syndrome).
Important warnings
- Before starting, check blood pressure, ALT and full blood count; liver enzymes at least every four weeks for the first 6 months, then regularly; weekly if ALT is 2- to 3-fold the upper limit of normal.
- Teriflunomide stays in the body for a long time; an accelerated elimination procedure (e.g. with cholestyramine or activated charcoal) is available (see the full text).
- Interstitial lung disease and pulmonary hypertension, which may be fatal, have been reported.
- Peripheral neuropathy: if confirmed, consider stopping and accelerated elimination.
- Avoid live attenuated vaccines; consider infection risk.
Side effects
- Most frequent (7 mg and 14 mg): headache (17.8%, 15.7%), diarrhoea (13.1%, 13.6%), increased ALT (13%, 15%), nausea (8%, 10.7%) and alopecia (9.8%, 13.5%); mostly mild to moderate and transient.
Interactions
- Potent CYP and transporter inducers (rifampicin, carbamazepine, phenobarbital, phenytoin, St John's wort) reduce exposure by approximately 40% – use with caution.
- Rosuvastatin exposure is markedly increased – reduce the rosuvastatin dose by 50%; caution with other BCRP and OATP substrates (e.g. methotrexate, other statins).
- Cholestyramine and activated charcoal rapidly lower teriflunomide levels.
Pregnancy and breastfeeding
- Contraindicated in pregnancy (may cause serious birth defects); exclude pregnancy before starting.
- The risk of male-mediated embryo-foetal toxicity is considered low.
Summary of the official product information, written with AI on 2026-10-29. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.
Common questions – ask Medelix
For patients
Package leaflet, verbatim
This product has no separate US patient information.
Authorisation and brand names by country
Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.
EU – centrally authorised (all member states)
- AubagioSanofi Winthrop Industrie · EMEA/H/C/002514
- Teriflunomide Accord · genericAccord Healthcare S.L.U. · EMEA/H/C/005960
- Teriflunomide Viatris (previously Teriflunomide Mylan) · genericViatris Limited · EMEA/H/C/005962
Source: European Medicines Agency (EMA), product information
Austria
- TerebyoSandoz Gmbh · 1 register entry
- Teriflunomid +pharma+pharma Arzneimittel Gmbh · 1 register entry
- Teriflunomid DevatisDevatis Gmbh · 1 register entry
- Teriflunomid GenericonGenericon Pharma Gesellschaft M.B.H. · 1 register entry
- Teriflunomid GlenmarkGlenmark Arzneimittel Gmbh · 1 register entry
- Teriflunomid HcsHcs Bvba · 1 register entry
- Teriflunomid RatiopharmTeva B.V · 1 register entry
- Teriflunomid StadaStada Arzneimittel Gmbh · 2 register entries
- Teriflunomid ZentivaZentiva, K.S. · 1 register entry
- Teriflunomide G.L.G.L. Pharma Gmbh · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Germany
- TerebyoHexal Ag · 1 register entry
- TeriflagoTad Pharma Gmbh · 1 register entry
- Teriflu ViatrisViatris Germany Gmbh · 1 register entry
- Teriflunomid1 A Pharma Gmbh, Betapharm Arzneimittel Gmbh, Hexal Ag, 123 Acurae Pharma Gmbh, Vivanta Generics S.R.O., G.L. Pharma Gmbh, Neuraxpharm Arzneimittel Gmbh, Ratiopharm Gmbh, Puren Pharma Gmbh & Co. Kg, Glenmark Arzneimittel Gmbh, Devatis Gmbh, Heumann Pharma Gmbh & Co. Generica Kg, Zentiva Pharma Gmbh, Amarox Pharma Gmbh, Elpen Pharmaceutical Co. Inc., Olpha As, Stadapharm Gmbh, Abdi Farma Gmbh, Axunio Pharma Gmbh, Aliud Pharma Gmbh · 22 register entries
- TheditraxPharmathen S.A. · 1 register entry
Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-29
Turkey
- AubagioSANOFİ SAĞLIK ÜRÜNLERİ LTD. ŞTİ. · 1 register entry
- AvonomideTEVA İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- AvoranSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- BaudaABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- FlunigenGENVEON İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- FlunotuONKO İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- RepisodeFARMA-TEK İLAÇ SAN. VE TİC. A.Ş. · 1 register entry
- TeflimesTEVA PHARMA İLAÇ SAN.VE TİC. A.Ş. · 1 register entry
- TerigioSABA İLAÇ SAN. VE TİC. A.Ş. · 2 register entries
- TheiramidİLKO İLAÇ SAN.VE TİC. A.Ş. · 1 register entry
Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16
Brand names in 28 more European countries
- Belgium
- Terebyo, Teriflunomid Eurogenerics, Teriflunomide Eg, Teriflunomide Eurogenerics, Teriflunomide Krka
- Bulgaria
- Terebyo, Teriflunomide Msn, Арегалу, Боксарид, Клефирем, Терифлуномид Деватис, Терифлуномид Зентива, Терифлуномид Фармасайънс
- Croatia
- Aregalu, Telirem, Telunis, Tergio, Teriflunomid, Tifay
- Cyprus
- Aregalu, Arogio, Feple, Telirem, Tergio, Teriflunomide Msn, Teriflunomide Sapiens, Teriflunomide Stada, Teriflunomide Teva
- Czechia
- Aregalu, Boxarid, Bozilos, Clefirem, Terebyo, Teriflunomid +pharma, Teriflunomid Abdi, Teriflunomid Zentiva, Teriflunomide Auxpharma, Teriflunomide G.L. Pharma, Teriflunomide Glenmark, Teriflunomide Msn, Teriflunomide Neuraxpharrn, Teriflunomide Pharmathen, Teriflunomide Teva, Teriflunomide Vipharm, Tifay
- Denmark
- Clefirem, Teriflunomid Devatis, Teriflunomid Pharmathen, Teriflunomid Stada, Teriflunomid Zentiva, Teriflunomide, Theditrax Pharmathen
- Estonia
- Aregalu, Boxarid, Telirem, Tenamid, Terebyo, Teriflunomide Glenmark, Teriflunomide Teva, Teriflunomide Tevapharm, Teriflunomide Zentiva, Tifay
- Finland
- Clefirem, Teriflunomide Avansor, Teriflunomide Devatis, Teriflunomide Glenmark, Teriflunomide Krka, Teriflunomide Olpha, Teriflunomide Orion, Teriflunomide Ratiopharm, Teriflunomide Sandoz, Teriflunomide Stada
- France
- Terebyo, Teriflunomide Arrow, Teriflunomide Biogaran, Teriflunomide Cristers, Teriflunomide Eg, Teriflunomide Evolugen, Teriflunomide Hcs, Teriflunomide Neuraxpharm, Teriflunomide Olpha, Teriflunomide Teva, Teriflunomide Viatris Sante, Teriflunomide Zentiva, Teriflunomide Zydus
- Greece
- Aregalu, Arogio, Feple, Terebyo, Tergio, Teriflunomide Genepharm, Teriflunomide Stada, Teriflunomide Teva, Teriflunomide Winmedica, Theditrax
- Hungary
- Aregalu, Arogio, Boxarid, Bozilos, Clefirem, Teriflunomid Galenika, Teriflunomid Onkogen, Teriflunomide
- Iceland
- Aubagio, Feple, Tergio, Teriflunomid, Teriflunomide Accord, Teriflunomide Krka, Teriflunomide Medical Valley, Teriflunomide Neuraxpharm, Teriflunomide Sandoz, Teriflunomide Stada, Teriflunomide Teva, Teriflunomide Viatris, Tifay
- Ireland
- Teriflunomide Clonmel
- Italy
- Clefirem, Terebyo, Tergio, Teriflunomide Abdi, Teriflunomide Aurobindo, Teriflunomide Dr. Reddys, Teriflunomide Eg, Teriflunomide Glenmark, Teriflunomide Hcs, Teriflunomide Teva Italia, Teriflunomide Viatris Pharma, Teriflunomide Zentiva
- Latvia
- Aregalu, Boxarid, Clefirem, Terebyo, Teriflunomide Glenmark, Teriflunomide Lv System Service Sia, Teriflunomide Olpha, Teriflunomide Stada, Teriflunomide Tevapharm, Teriflunomide Zentiva, Tifay
- Liechtenstein
- Aubagio, Teriflunomide Accord, Teriflunomide Viatris
- Lithuania
- Aregalu, Boxarid, Clefirem, Tenamid, Terebyo, Teriflunomide Glenmark, Teriflunomide Olpha, Teriflunomide Stada, Teriflunomide Zentiva, Tifay
- Luxembourg
- Teriflunomide Eg, Teriflunomide Eurogenerics
- Malta
- Telirem, Tergio, Teriflunomide
- Netherlands
- Teriflox, Teriflunomide Abdi, Teriflunomide Amarox, Teriflunomide Aurobindo, Teriflunomide Centrafarm, Teriflunomide Cf, Teriflunomide Devatis, Teriflunomide Glenmark, Teriflunomide Sandoz, Teriflunomide Teva, Teriflunomide Vivanta
- Norway
- Aubagio, Clefirem, Teriflunomid Devatis, Teriflunomid Neuraxpharm, Teriflunomid Zentiva, Teriflunomide
- Poland
- Aregalu, Boxarid, Bozilos, Clefirem, Terebyo, Teriflunomid Adamed, Teriflunomide +pharma, Teriflunomide Aurovitas, Teriflunomide G.L. Pharma, Teriflunomide Glenmark, Teriflunomide Medical Valley, Teriflunomide Msn, Teriflunomide Neuraxpharm, Teriflunomide Pharmathen, Teriflunomide Ranbaxy, Teriflunomide Vipharm, Teriflunomide Zentiva, Tifay
- Portugal
- Teriflunomida Basi, Teriflunomida Bluepharma, Teriflunomida Generis, Teriflunomida Glenmark, Teriflunomida Krka, Teriflunomida Pharmakern, Teriflunomida Ratiopharm, Teriflunomida Sandoz, Teriflunomida Stada, Teriflunomida Viatris, Teriflunomida Zentiva, Teriflunomide Liconsa
- Romania
- Boxarid, Bozilos, Feple, Terebyo, Teriflunomidă Dr. Reddy’s, Teriflunomidă Msn, Teriflunomidă Stada, Teriflunomidă Terapia, Teriflunomidă Teva, Teriflunomidă Zentiva
- Slovakia
- Aregalu, Boxarid, Bozilos, Clefirem, Terebyo, Teriflago, Teriflunomid Galenika, Teriflunomid Krka, Teriflunomid Teva, Teriflunomide G.L. Pharma, Teriflunomide Glenmark, Teriflunomide Hcs, Teriflunomide Msn, Teriflunomide Neuraxpharm, Teriflunomide Pharmathen, Teriflunomide Stada, Teriflunomide Vipharm, Teriflunomide Zentiva
- Slovenia
- Aregalu, Clefirem, Terebyo, Teriflunomid Galenika, Teriflunomid Msn
- Spain
- Clefirem, Teriflunomida Aurovitas, Teriflunomida Dr. Reddys, Teriflunomida Efg Stadafarma, Teriflunomida Glenmark, Teriflunomida Kern Pharma, Teriflunomida Krka, Teriflunomida Neuraxpharm, Teriflunomida Sandoz, Teriflunomida Stada, Teriflunomida Stadafarma, Teriflunomida Tarbis, Teriflunomida Tevagen, Teriflunomida Viatris Pharmaceuticals, Teriflunomida Vivanta, Teriflunomida Zentiva, Theditrax
- Sweden
- Clefirem, Teriflunomid Devatis, Teriflunomid Sun, Teriflunomid Zentiva, Teriflunomide
EMA – Article 57 product data (EU/EEA), 2026-10-29
Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.
Other substances in the same group
Another question about this substance?
Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.
Sources
- European Medicines Agency. Aubagio – EPAR, Product Information. 2026-10-28. https://www.ema.europa.eu/en/documents/product-information/aubagio-epar-product-information_en.pdf
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- EMA – Article 57 product data (EU/EEA), 2026-10-29. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
- TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
- Wikidata (CC0): ATC L04AK.
Editorial: Medelix editorial team · last updated 2026-10-28 · How these pages are made · Report an error
Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.